Articles
Search articles by year of publication.
Search articles by industry.
Industry
- Aerospace
- Agriculture
- Alcohol
- Apparel
- Artificial Intelligence
- Arts
- Automotive
- Biotechnology
- Canada
- Corporate Strategy
- Crypto
- Currency
- Customer Strategy
- Digitalization
- E-commerce
- Education
- Education Technology
- Employee Ownership
- Energy
- Entertainment
- Entrepreneurship
- Fashion
- FinTech
- Finance
- Financial Services
- Food
- Gaming
- Government
- Grocery
- Growth Strategy
- Healthcare
- Industrial
- Information Technology
- Infrastructure
- Interview
- Marijuana
- Marketing Strategy
- Media and Entertainment
- Mergers and Acquisitio...
- Metals and Mining
- Music
- Pharmaceuticals
- Power and Utilities
- Private Equity
- Product Strategy
- Products and Consumer Goods
- Professional Services
- Racing
- Real Estate
- Research and Developme...
Teva: Don't Be so Generic
In the face of squeezed margins in the generics industry, Teva must diversify revenues into the nascent biosimilar space to remain profitable.
The Biosimilar Onslaught
Pharmaceutical companies face huge revenue uncertainties after the loss of patent exclusivity; but not all is lost.